Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31659

1.

A prospective cross-sectional study on quality of life and treatment satisfaction in type 2 diabetic patients with retinopathy without other major late diabetic complications.

Alcubierre N, Rubinat E, Traveset A, Martinez-Alonso M, Hernandez M, Jurjo C, Mauricio D.

Health Qual Life Outcomes. 2014 Aug 20;12(1):131. [Epub ahead of print]

PMID:
25138117
[PubMed - as supplied by publisher]
Free Article
2.

Synthesis, in vitro and in silico studies of a PPARγ and GLUT-4 modulator with hypoglycemic effect.

Navarrete-Vázquez G, Torres-Gómez H, Hidalgo-Figueroa S, Ramírez-Espinosa JJ, Estrada-Soto S, Medina-Franco JL, León-Rivera I, Alarcón-Aguilar FJ, Almanza-Pérez JC.

Bioorg Med Chem Lett. 2014 Aug 1. pii: S0960-894X(14)00792-6. doi: 10.1016/j.bmcl.2014.07.068. [Epub ahead of print]

PMID:
25131539
[PubMed - as supplied by publisher]
3.

Xenograft of microencapsulated sertoli cells for the cell therapy of type 2 diabetes mellitus in spontaneously diabetic nonhuman primates: preliminary data.

Luca G, Cameron DF, Arato I, Mancuso F, Linden EH, Calvitti M, Falabella G, Szekeres K, Bodo M, Ricci G, Hansen BC, Calafiore R.

Transplant Proc. 2014 Jul-Aug;46(6):1999-2001. doi: 10.1016/j.transproceed.2014.06.053.

PMID:
25131093
[PubMed - in process]
4.

Metabolic surgery for the treatment of type 2 diabetes in pancreas after kidney transplant candidates.

Gullo-Neto S, Vontobel Padoin A, Queiroz de Carvalho JE, Wendling R, Traesel MA, Kroth L, Miranda C, Balestro AC, Siqueira R, Chao Lisot B, Lima S, Corá Mottin C, Saitovitch D.

Transplant Proc. 2014 Jul-Aug;46(6):1741-4. doi: 10.1016/j.transproceed.2014.05.005.

PMID:
25131025
[PubMed - in process]
5.

Distinct clinical and laboratory characteristics of latent autoimmune diabetes in adults in relation to type 1 and type 2 diabetes mellitus.

Pipi E, Marketou M, Tsirogianni A.

World J Diabetes. 2014 Aug 15;5(4):505-10. doi: 10.4239/wjd.v5.i4.505. Review.

PMID:
25126396
[PubMed]
Free PMC Article
6.

Cross-talk between SIRT1 and endocrine factors: effects on energy homeostasis.

Quiñones M, Al-Massadi O, Fernø J, Nogueiras R.

Mol Cell Endocrinol. 2014 Aug 7. pii: S0303-7207(14)00236-6. doi: 10.1016/j.mce.2014.08.002. [Epub ahead of print]

PMID:
25109279
[PubMed - as supplied by publisher]
7.

Preclinical characterization of recombinant human tissue kallikrein-1 as a novel treatment for type 2 diabetes mellitus.

Kolodka T, Charles ML, Raghavan A, Radichev IA, Amatya C, Ellefson J, Savinov AY, Nag A, Williams MS, Robbins MS.

PLoS One. 2014 Aug 6;9(8):e103981. doi: 10.1371/journal.pone.0103981. eCollection 2014.

PMID:
25100328
[PubMed - in process]
Free PMC Article
8.

Use of Dipeptidyl Peptidase - 4 inhibitors for type 2 diabetes mellitus and risk of fracture.

Driessen JH, van Onzenoort HA, Henry RM, Lalmohamed A, van den Bergh JP, Neef C, Leufkens HG, de Vries F.

Bone. 2014 Aug 2. pii: S8756-3282(14)00293-2. doi: 10.1016/j.bone.2014.07.030. [Epub ahead of print]

PMID:
25093264
[PubMed - as supplied by publisher]
9.

Significance of CXCL12 in Type 2 Diabetes Mellitus and Its Associated Complications.

Karimabad MN, Hassanshahi G.

Inflammation. 2014 Aug 2. [Epub ahead of print]

PMID:
25085744
[PubMed - as supplied by publisher]
10.

Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials.

Vora J, Christensen T, Rana A, Bain SC.

Diabetes Ther. 2014 Aug 1. [Epub ahead of print]

PMID:
25081590
[PubMed - as supplied by publisher]
12.

Metabolic signaling of insulin secretion by pancreatic β-cell and its derangement in type 2 diabetes.

Zou CY, Gong Y, Liang J.

Eur Rev Med Pharmacol Sci. 2014 Aug;18(15):2215-27.

PMID:
25070829
[PubMed - in process]
13.

Are Patients with Diabetes Mellitus Satisfied with Technologies Used to Assist with Diabetes Management and Coping?: A Structured Review.

Harrison S, Stadler M, Ismail K, Amiel S, Herrmann-Werner A.

Diabetes Technol Ther. 2014 Jul 28. [Epub ahead of print]

PMID:
25069057
[PubMed - as supplied by publisher]
14.

[Diabetes mellitus type 1 and 2. Flexible therapy with insulin degludec].

Rausch R.

Med Monatsschr Pharm. 2014 Jul;37(7):273-4. German. No abstract available.

PMID:
25065174
[PubMed - indexed for MEDLINE]
15.

PPARβ/δ prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism.

Salvadó L, Barroso E, Gómez-Foix AM, Palomer X, Michalik L, Wahli W, Vázquez-Carrera M.

Diabetologia. 2014 Jul 26. [Epub ahead of print]

PMID:
25063273
[PubMed - as supplied by publisher]
16.

[Lixisenatide (Lyxumia), subcutaneous].

[No authors listed]

J Pharm Belg. 2014 Jun;(2):57-9. French. No abstract available.

PMID:
25055456
[PubMed - indexed for MEDLINE]
17.

The risk for diabetic nephropathy is low in young adults in a 17-year follow-up of the Diabetes Incidence Study in Sweden (DISS). Higher age and BMI at diabetes onset can be important risk factors.

Svensson MK, Tyrberg M, Nyström L, Arnqvist HJ, Bolinder J, Ostman J, Gudbjörnsdottir S, Landin-Olsson M, Eriksson JW.

Diabetes Metab Res Rev. 2014 Jul 5. doi: 10.1002/dmrr.2574. [Epub ahead of print]

PMID:
25044633
[PubMed - as supplied by publisher]
18.

High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875.

Srivastava A, Yano J, Hirozane Y, Kefala G, Gruswitz F, Snell G, Lane W, Ivetac A, Aertgeerts K, Nguyen J, Jennings A, Okada K.

Nature. 2014 Jul 20. doi: 10.1038/nature13494. [Epub ahead of print]

PMID:
25043059
[PubMed - as supplied by publisher]
19.

Alterations in insulin-signaling and coagulation pathways in platelets during hyperglycemia-hyperinsulinemia in healthy non-diabetic subject.

Rao AK, Freishtat RJ, Jalagadugula G, Singh A, Mao G, Wiles A, Cheung P, Boden G.

Thromb Res. 2014 Jul 6. pii: S0049-3848(14)00355-7. doi: 10.1016/j.thromres.2014.06.029. [Epub ahead of print]

PMID:
25042561
[PubMed - as supplied by publisher]
20.

Emerging Roles of Dipeptidyl Peptidase 4 Inhibitors: Anti-Inflammatory and Immunomodulatory Effect and Its Application in Diabetes Mellitus.

Yang L, Yuan J, Zhou Z.

Can J Diabetes. 2014 Jul 14. pii: S1499-2671(14)00044-6. doi: 10.1016/j.jcjd.2014.01.008. [Epub ahead of print] Review.

PMID:
25034244
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk